This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / SOPHiA GENETICS $50M Public Offering
Business public offering

SOPHiA GENETICS $50M Public Offering

Analysis based on 7 articles · First reported Jun 16, 2026 · Last updated Jun 17, 2026

Sentiment
20
Attention
4
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The public offering by Sophia Genetics is expected to raise approximately $50 million, providing capital for the company's operations and growth. This could lead to increased investor confidence in Sophia Genetics, potentially impacting its stock price positively.

Biotechnology Healthcare Technology
Event Summary

Sophia Genetics announced and priced a public offering of 10,526,000 ordinary shares at $4.75 per share, aiming to raise approximately $50 million in gross proceeds. The offering is expected to close on June 18, 2026. Toronto-Dominion Bank — TD Cowen is serving as the lead book-running manager, with Guggenheim Partners as a book-running manager, and BTIG and Craig-Hallum as lead managers. The United States — United States Securities and Exchange Commission had previously declared the registration statement effective.

Entities Involved
stock
Sophia Genetics
Sophia Genetics is conducting a public offering of its ordinary shares to raise approximately $50 million, which will impact its capital structure and financial liquidity.
Importance 100.0 Sentiment 20.0
subs
Toronto-Dominion Bank — TD Cowen
Toronto-Dominion Bank — TD Cowen is acting as the lead book-running manager for the public offering by Sophia Genetics, facilitating the transaction.
Importance 70.0 Sentiment 10.0
priv
Guggenheim Partners
Guggenheim Partners is acting as a book-running manager for the public offering by Sophia Genetics.
Importance 50.0 Sentiment 10.0
priv
Craig-Hallum Capital Group
Craig-Hallum is acting as a lead manager for the public offering by Sophia Genetics.
Importance 40.0 Sentiment 10.0
priv
BTIG
BTIG is acting as a lead manager for the public offering by Sophia Genetics.
Importance 40.0 Sentiment 10.0
govactor
United States — United States Securities and Exchange Commission
The United States — United States Securities and Exchange Commission declared the registration statement for Sophia Genetics's offering effective, ensuring regulatory compliance.
Importance 10.0 Sentiment 0.0
Relationships
Toronto-Dominion Bank — TD Cowen related ↔ United States — United States Securities and Exchange Commission
Guggenheim Partners related ↔ United States — United States Securities and Exchange Commission
BTIG related ↔ United States — United States Securities and Exchange Commission
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.